63424-42-0

Basic information

• Product Name: N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide
• Synonyms: N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide;2-hexadecanoylamino-4-nitrophenyl-beta-D-galactopyranoside;N-[2-(β-D-Galactopyranosyloxy)-5-nitrophenyl]hexadecanamide
• CAS NO: 63424-42-0
• Molecular Formula: C28H46N2O9
• Molecular Weight: 554.67284
• EINECS: 264-134-3
• Product Categories: Substrates
• Mol File: 63424-42-0.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 738.2°Cat760mmHg
• Flash Point: 400.3°C
• Appearance: /
• Density: 1.225g/cm³
• CAS DataBase Reference: N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide(63424-42-0)
• EPA Substance Registry System: N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide(63424-42-0)

Safety Data

• Hazardous Substances Data: 63424-42-0(Hazardous Substances Data)

Usage

Description

N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide, also known as 2-Hexadecanoylamino-4-nitrophenyl β-D-galactopyranoside, is a chromogenic substrate that plays a significant role in the medical field, particularly for the diagnosis of specific diseases.

Uses

Used in Medical Diagnostics:
N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide is used as a chromogenic substrate for the diagnosis of Krabbe's disease. This application is crucial as it aids in the detection and monitoring of this rare genetic disorder, enabling timely intervention and treatment strategies.
Used in Research and Development:
In the scientific community, N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide serves as a valuable tool in research and development. It can be utilized to study the enzymatic activity related to Krabbe's disease, furthering our understanding of the disease's pathology and potentially leading to the discovery of new therapeutic approaches.
Used in Pharmaceutical Industry:
N-[2-(beta-D-galactopyranosyloxy)-5-nitrophenyl]palmitamide may also be employed in the pharmaceutical industry for the development of diagnostic kits and reagents specifically designed for Krabbe's disease. This can contribute to more accurate and efficient diagnostic processes, ultimately benefiting patients and healthcare providers alike.